Register of
Medicinal Products
Human medicines
Veterinary medicines
Medical nutritions
User
Listings
Data download
Human medicines
Search for medicinal products
Search for packages
ATC tree
User manual
Print
Betafuse
General data
Product class:
Medicinal product with marketing authorization
Medicinal product class:
Veterinary medicine
Name of medicinal product:
Betafuse
Active substances:
Betamethasone+Fusidic acid
Estonian
,
English
,
Latin
ATC code:
QD07CC80
Dosage form:
gel
Strength:
1mg+5mg 1g
Legal status for supply*:
Subject to medicinal prescription
Summary of product characteristics (SPC):
(last updated September 2, 2021)
Package information leaflet (PIL):
EST
(last updated September 2, 2021)
Labelling:
(last updated September 2, 2021)
Indication:
For the treatment of acute surface pyoderma in the dog, such as acute moist dermatitis (‘hot spots’) and intertrigo (skin fold dermatitis), caused by Gram-positive bacteria sensitive to fusidic acid.
Safety features:
No
Marketing authorization
Marketing authorization holder:
Norbrook Laboratories (Ireland) Limited
Marketing authorization number:
1992
Marketing authorization issued on:
September 30, 2016
Marketing authorization expires on:
Unlimited
Marketing authorization procedure type:
Decentralised
Assessment report:
(last updated February 7, 2017)
Packages approved by this marketing authorization
Package code
Name of medicinal product
Dosage form
Package
Legal status
Reimbursements
Reference price
Last imported
PƤritolumaa
Additional information
1693368
Betafuse
gel
1mg +5mg 1g 15g 1TK
Prescription
09.02.2023
1693492
Betafuse
gel
1mg +5mg 1g 30g 1TK
Prescription
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader from
here